Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 18/20 | 0.78 |
| ▸ | CYP11B2 | P19099 | 18/20 | 0.78 |
| ▸ | FLT3 | P36888 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1514536 | 0.88 | FLT3 (0.59) | CYP11B1CYP11B2FLT3ALDH1A1NPSR1 | |
| SCHEMBL20460028 | 0.88 | CYP11B2 (1.00) | CYP11B1CYP11B2 | |
| SCHEMBL20938090 | 0.82 | CYP11B1 (0.54) | CYP11B1CYP11B2FLT3ALDH1A1NPSR1 | |
| SCHEMBL2653236 | 0.80 | GABRG2 (0.63) | CYP11B1CYP11B2FLT3 | |
| SCHEMBL26073212 | 0.79 | ABCG2 (0.55) | CYP11B1CYP11B2FLT3ALDH1A1NPSR1 | |
| SCHEMBL23519333 | 0.79 | ABCG2 (0.55) | CYP11B1CYP11B2FLT3ALDH1A1NPSR1 | |
| SCHEMBL24322305 | 0.79 | FLT3 (0.52) | CYP11B1CYP11B2FLT3ALDH1A1NPSR1 | |
| SCHEMBL2924723 | 0.78 | PIK3CD (0.50) | CYP11B1CYP11B2FLT3 | |
| SCHEMBL24322662 | 0.78 | ABCG2 (0.56) | CYP11B1CYP11B2FLT3ALDH1A1NPSR1 | |
| SCHEMBL20114641 | 0.78 | ABCG2 (0.56) | CYP11B1CYP11B2FLT3ALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220077402-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE ORGANIC COMPOUND | LG DISPLAY CO., LTD. (KR) | 2022-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220077402-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE ORGANIC COMPOUND | OCIAD1, OCIAD2, NLRP3 | CYP11B1 1105/4885CYP11B2 887/4885FLT3 3901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.